Analysts Viewpoint
SILO Pharma Inc’s latest rating changes from various analysts
SILO Pharma Inc’s recently made public that its CEO and President Weisblum Eric acquired Company’s shares for reported $4926.0 on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.